Vascular Access Center (Grupo Estudos Vasculares-GEV), Porto, Portugal; Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário do Porto, Porto, Portugal; ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal.
Vascular Access Center (Grupo Estudos Vasculares-GEV), Porto, Portugal; Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Ann Vasc Surg. 2023 Aug;94:280-288. doi: 10.1016/j.avsg.2023.02.028. Epub 2023 Mar 1.
Venous scarring at the elbow is a common problem that can cause early and late forearm arteriovenous fistula (AVF) dysfunction in hemodialysis patients. However, any effort to prolong the long-term patency of distal vascular accesses could benefit the patient's survival, maximizing the use of restricted venous patrimony. This study aims to report a single-center experience in the recovery of distal autologous AVF with venous outflow obstruction at the elbow using different surgical techniques.
Retrospective observational study of all patients treated at a single vascular access center from January 2011 to March 2022, with dysfunctional forearm AVFs presenting with outflow stenosis or occlusions at the elbow treated by open surgery, using 3 different surgical techniques. Demographics and clinically relevant data were collected. Evaluated endpoints included primary, assisted primary, and secondary patency rates at 1 and 2 years.
Twenty-three patients with elbow-blocked outflow forearm AVFs have been treated with a mean age of 64 ± 15 years. The majority (96%) had a radiocephalic fistula. The median time from vascular access creation to intervention was 34.5 months (12-216 months). A total of 24 procedures have been performed using 3 different surgical techniques for bypassing the obstructed venous outflow at the elbow. Technical success was achieved in 96% of the surgically treated patients. Primary and secondary patency rates at 1 year were 67.4% and 89.4%, respectively, and 52.9% and 82.0% at 2 years, with a median follow-up of 19 months (6-92 months).
AVFs outflow stenosis or occlusions at the elbow not amenable to endovascular therapy could lead to vascular access abandonment. Our study demonstrates multiple surgical solutions to avoid this adverse outcome. Elbow venous outflow surgical reconstruction seems effective for distal vascular access preservation. Close surveillance is essential for timely endovascular treatment of newly developed stenosis at the venous drainage.
肘部静脉瘢痕是一个常见的问题,可导致血液透析患者早期和晚期前臂动静脉瘘(AVF)功能障碍。然而,任何延长远端血管通路长期通畅的努力都将使患者受益,最大限度地利用有限的静脉资源。本研究旨在报告单中心使用不同手术技术恢复肘部静脉流出阻塞的自体 AVF 的经验。
对 2011 年 1 月至 2022 年 3 月期间在一个血管通路中心治疗的所有患者进行回顾性观察研究,对于肘部静脉流出狭窄或闭塞导致功能障碍的前臂 AVF 患者,采用 3 种不同的手术技术进行开放手术治疗。收集患者的人口统计学和临床相关数据。评估终点包括 1 年和 2 年时的原发性、辅助原发性和继发性通畅率。
23 例肘部静脉流出受阻的前臂 AVF 患者接受了治疗,平均年龄为 64 ± 15 岁。大多数(96%)为头静脉-桡动脉内瘘。从血管通路建立到干预的中位时间为 34.5 个月(12-216 个月)。采用 3 种不同的手术技术共完成 24 例旁路手术,以绕过肘部阻塞的静脉流出。手术治疗的患者中,技术成功率达到 96%。1 年时的原发性和继发性通畅率分别为 67.4%和 89.4%,2 年时分别为 52.9%和 82.0%,中位随访时间为 19 个月(6-92 个月)。
肘部静脉流出狭窄或闭塞且不适合血管内治疗可能导致血管通路废弃。我们的研究表明,有多种手术解决方案可避免这种不良结局。肘部静脉流出重建手术似乎对保存远端血管通路有效。对于新出现的静脉引流处狭窄,需要密切监测并及时进行血管内治疗。